Association of tumor necrosis factor microsatellite polymorphisms with HLA-DRB1*04-bearing haplotypes in rheumatoid arthritis patients

Arthritis and Rheumatism

Volumn 39, Issue 7, 1996, Pages 1109-1114

  Hajeer, Ali H ^a,b   Worthington, Jane ^a   Silman, Alan J ^a   Ollier, William E R ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DR1 ANTIGEN;

ALLELE; ARTICLE; GENE FREQUENCY; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HLA TYPING; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

ALLELES; ARTHRITIS, RHEUMATOID; GENE FREQUENCY; HAPLOTYPES; HLA-DR ANTIGENS; HUMANS; LINKAGE (GENETICS); MICROSATELLITE REPEATS; POLYMORPHISM, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0029900519     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.1780390706     Document Type: Article

References (32)

1. Panayi GS, Lanchbury JS, Kingsley GH: The importance of the T cell in initiating and maintaining the chronic synovitis of rheumatoid arthritis. Arthritis Rheum 35:729-735, 1992
2. Buchan G, Barrett K, Turner M, Chantry D, Maini RN, Feldmann M: Interleukin-1 and tumour necrosis factor mRNA expression in rheumatoid arthritis: prolonged production of IL-1. Clin Exp Immunol 73:449-455, 1988
3. Brennan FM, Field M, Chu CQ, Feldmann M, Maini RN: Cytokine expression in rheumatoid arthritis. Br J Rheumatol 30 (suppl 1):76-80, 1991
4. Stastny P: Association of B-cell alloantigen DRw4 with rheumatoid arthritis. N Engl J Med 298:869-871, 1978
5. Ollier W, Thompson W: Population genetics of rheumatoid arthritis. Rheum Dis Clin North Am 18:741-759, 1992
6. Gregersen PK, Silver J, Winchester RJ: The shared epitope hypothesis: an approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 30:1205-1213, 1987
7. Thomson W, Pepper L, Payton A, Carthy D, Scott D, Ollier W, Silman A, Symmons D: Absence of an association between HLA-DRB1*04 and rheumatoid arthritis in newly diagnosed cases from the community. Ann Rheum Dis 52:539-541, 1993
8. Jaraquemada D, Ollier W, Awad J, Young A, Festenstein H: HLA and rheumatoid arthritis: susceptibility or severity? Dis Markers 4:43-53, 1986
9. Wey CM, Xie CP, Goronzy JJ: Homozygosity for the HLA-DRB1 allele selected for extra articular manifestations in rheumatoid arthritis. J Clin Invest 89:2033-2039, 1992
10. Wordsworth P, Pile KD, Buckley JD, Lanchbury JSS, Ollier B, Lathrop M, Bell JI: HLA heterozygosity contributes to susceptibility to rheumatoid arthritis. Am J Hum Genet 51:585-591, 1992
11. Gough A, Faint J, Salmon M, Hassell A, Wordsworth P, Pilling D, Birley A, Emery P: Genetic typing of patients with inflammatory arthritis at presentation can be used to predict outcome. Arthritis Rheum 37:1166-1170, 1994
12. MacGregor A, Ollier W, Thomson W, Jawaheer D, Silman A: HLA-DRB1*0401/0404 genotype and rheumatoid arthritis: increased association in men, young age at onset and disease severity. J Rheumatol 22:1032-1036, 1995
13. Roudier J, Petersen J, Rhodes GH, Luka J, Carson DA: Susceptibility to rheumatoid arthritis maps to a T-cell epitope shared by the HLA-Dw4 DR B-1 chain and the Epstein-Barr virus glycoprotein gp110. Proc Natl Acad Sci U S A 86:5104-5108, 1989
14. Albani S, Tuckwell JE, Esparza L, Carson DA, Roudier J: The susceptibility sequence to rheumatoid arthritis is a cross-reactive B cell epitope shared by the Escherichia coli heat shock protein dnaJ and the histocompatibility leukocyte antigen DRB1*0401 molecule. J Clin Invest 89:327-331, 1992
15. Albani S, Keystone EC, Nelson JL, Ollier WER, La Cava A, Montemayor AC, Weber DA, Montecucco C, Martini A, Carson DA: Positive selection in autoimmunity: abnormal immune responses to a bacterial dnaJ antigenic determinant in patients with early rheumatoid arthritis. Nature Med 1:448-452, 1995
16. Bhayani HR, Hedrick SM: The role of polymorphic amino acids of the MHC molecules in the selection of the T cell repertoire. J Immunol 146:1093-1098, 1991
17. Elliott MJ, Maini RN, Feldmann M, Long-Fox A, Charles P, Bijl H, Woody JN: Repeated therapy with monoclonal antibody to tumour necrosis factor a (cA2) in patients with rheumatoid arthritis. Lancet 344:1125-1127, 1994
18. Carroll MC, Katzman P, Alicol EM, Koller BH, Geraghty DE, Orr HT, Strominger JL, Spies T: Linkage map of the major histocompatibility complex including the tumor necrosis factor genes. Proc Natl Acad Sci U S A 84:8535-8539, 1987
19. Webb GC, Chaplin DD: Genetic variability at the human tumor necrosis factor loci. J Immunol 145:1278-1285, 1990
20. Udalova IA, Ncdospasov SA, Webb GC, Chaplin DD, Turestskaya RL: Highly informative typing of the human TNF locus using six adjacent polymorphic markers. Genomics 16:180-186, 1993
21. Pociot F, Briant L, Jongeneel CV, Mölvig J, Worsaae H, Abbal M, Thomsen M, Nerup J, Cambon-Thomsen A: Association of tumor necrosis factor (TNF) and class II major histocompatibility complex alleles with the secretion of TNFα and TNFβ by human mononuclear cells: a possible link to insulin-dependent diabetes mellitus. Eur J Immunol 23:224-231, 1993
22. Silman AJ, MacGregor AJ, Thomson W, Holligan S, Carthy D, Farhan A, Ollier WER: Twin concordance rates for rheumatoid arthritis: results from a nationwide study. Br J Rheumatol 32:903-907, 1993
23. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger TA Jr, Mitchell DM, Neustadt DH, Pinals RS, Schaller JG, Sharp JT, Wilder RL, Hundcr GG: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315-324, 1988
24. MacGregor AJ, Bamber S, Silman AJ: A comparison of the performance of different methods of disease classification for rheumatoid arthritis: results of an analysis from a nationwide twin study. J Rheumatol 21:1420-1426, 1994
25. Mittal KK, Mickey MR, Singal DP, Terasaki PI: Serotyping for homotransplantation. XVIII. Refinement of microdroplet lymphocyte cytotoxicity test. Transplantation 6:913-927, 1968
26. Thomson W, Ollier WER: Non-radioactive ASO typing for class II. Eur J Immunogen 19:169-175, 1992
27. Jawaheer D, Ollier WER, Thomson W: Multiplex ARMS-RFLP: a rapid and simple method for HLA-DR4 subtyping. Eur J Immunogen 20:175-187, 1993
28. Ollier W, Venables PJW, Mumford PA, Maini RN, Awad J, Jaraquemada D, D'Amaro J, Festenstein H: HLA antigen associations with extra-articular rheumatoid arthritis. Tissue Antigens 24:279-291, 1984
29. Pociot F, Mölvig J, Wogensen L, Worsaae H, Daboge H, Baek L, Nerup J: A tumor necrosis factor beta gene polymorphism in relation to monokine secretion and insulin-dependent diabetes mellitus. Scand J Immmunol 33:37-49, 1991
30. Jacob CO, Fronek Z, Lewis GD, Koo M, Hansen JA, McDevitt HO: Heritable major histocompatibility complex class 11-associated differences in production of tumor necrosis factor a: relevance to genetic predisposition to systemic lupus erythematosus. Proc Natl Acad Sci U S A 87:1233-1237, 1990
31. Raum DD, Awdeh ZL, Yunis E, Gabbay KH: Extended haplotypes in type I diabetes mellitus. J Clin Invest 74:449-454, 1984
32. Davies EJ, Hillarby MC, Cooper RG, Hay EM, Green JR, Shah S, Bernstein RM, Holt PJL, Grennan DM: HLA-DQ, DR and complement C4 variants in systemic lupus erythematosus. Br J Rheumatol 32:870-875, 1993